Psoriasis is one of the most common autoimmune inflammatory diseases, and it affects more than 7.5 million adults in the U.S.

The key is knowing what's causing the itch and choosing the right treatment for the job. Tp find out more, we asked the ...

Psoriasis can affect any part of your skin. Sometimes it can affect multiple parts of your body.Your elbows, knees, trunk, ...

Four Phase 3 ICONIC trials assessed the oral IL-23 receptor antagonist icotrokinra in more than 2,500 patients with plaque ...

Explore why topical treatments are becoming a bigger part of modern skincare routines, from targeted ingredients and acne ...

Editors and experts agree these scalp soothers actually work.

MIMRYLO™ is the First and Only Hepcidin Mimetic Peptide Therapy Approved for the Treatment of Erythrocytosis in Adults ...

Daily products maintain hydration but can't fix serious skin problems. Seeking timely professional help provides an accurate ...

MIMRYLO is the First and Only Hepcidin Mimetic Peptide Therapy Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera, Offering a Novel Mechanism to Maintain Hematocrit Control, ...

Nonsteroidal topicals like roflumilast are enabling proactive, long-term psoriasis control across a broad range of patients, reducing reliance on corticosteroids and minimizing the need for systemic ...

A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...